Update in “The Sticky Cholesterol”: Lipoprotein(a) AKA Lp(a), Bob Harper, and Your Risk of Disease

If lipoprotein(a) was a stock, it would be time to invest. The interest is growing and growing.

The cynic would say that this is because an agent is in trials and the money for pharmacological therapy of this “sticky cholesterol”, also known as L(a), pronounced LP little a, will be flowing soon. The kind hearted would say that it is just the normal evolution of medical knowledge. I have written before about the high-profile health issues of one of the Biggest Loser…